Oppenheimer Initiates Regulus Therapeutics at Outperform With $7 Price Target

Oppenheimer开始对regulus therapeutics进行推荐，目标价为7美元。

MT Newswires · 08/02 07:38 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.